Follow
Dr. Rajni Verma
Dr. Rajni Verma
Genzada Pharmaceuticals, Kansas
Verified email at genzada.com - Homepage
Title
Cited by
Cited by
Year
Computer-aided protein directed evolution: a review of web servers, databases and other computational tools for protein engineering
R Verma, U Schwaneberg, D Roccatano
Computational and structural biotechnology journal 2 (3), e201209008, 2012
782012
A potential antitumor drug (arginine deiminase) reengineered for efficient operation under physiological conditions
L Zhu, R Verma, D Roccatano, Y Ni, ZH Sun, U Schwaneberg
ChemBioChem 11 (16), 2294-2301, 2010
342010
Molecular Modeling of Cetylpyridinium Bromide, a Cationic Surfactant, in Solutions and Micelle
Rajni Verma, Archana Mishra, Katie Mitchell-Koch
Journal of Chemical Theory and Computation 11 (11), 5415–5425, 2015
272015
Progress in Our Understanding of 19F Chemical Shifts
J Dahanayake, C Kasireddy, JP Karnes, R Verma, RM Steinert, ...
Annual Reports on NMR Spectroscopy 93, 2017
242017
Insight into the redox partner interaction mechanism in cytochrome P450BM‐3 using molecular dynamics simulations
R Verma, U Schwaneberg, D Roccatano
Biopolymers 101 (3), 197-209, 2014
222014
In Silico Studies of Small Molecule Interactions with Enzymes Reveal Aspects of Catalytic Function
R Verma, K Mitchell-Koch
Catalysts 7 (7), 212; doi:10.3390/catal7070212, 2017
202017
MAP2.03D: a Sequence/Structure Based Server for Protein Engineering
R Verma, U Schwaneberg, D Roccatano
ACS Synthetic Biology 1 (4), 139–150, 2012
202012
dRTP and dPTP a complementary nucleotide couple for the Sequence Saturation Mutagenesis (SeSaM) method
AJ Ruff, J Marienhagen, R Verma, D Roccatano, HG Genieser, ...
Journal of Molecular Catalysis B: Enzymatic 84, 40-47, 2012
192012
To keep or not to keep? the question of crystallographic waters for enzyme simulations in organic solvent
JN Dahanayake, DN Gautam, R Verma, KR Mitchell-Koch
Molecular simulation 42 (12), 1001-1013, 2016
172016
Tuning cationic micelle properties with an antioxidant additive: a molecular perspective
V Kumar, GM Sai, R Verma, KR Mitchell-Koch, D Ray, VK Aswal, ...
Langmuir 37 (15), 4611-4621, 2021
162021
Conformational Dynamics of the FMN-binding Reductase Domain of Monooxygenase P450BM-3
R Verma, U Schwaneberg, D Roccatano
Journal of Chemical Theory and Computation 9 (1), 96-105, 2013
152013
The Mutagenesis Assistant Program
R Verma, TS Wong, U Schwaneberg, D Roccatano
Directed Evolution Library Creation: Methods and Protocols, Methods in …, 2014
82014
Contrasting effect of 1-butanol and 1, 4-butanediol on the triggered micellar self-assemblies of C 16-type cationic surfactants
V Kumar, R Verma, D Satodia, D Ray, K Kuperkar, VK Aswal, ...
Physical Chemistry Chemical Physics 23 (35), 19680-19692, 2021
72021
Unraveling binding effects of cobalt (II) sepulchrate with the monooxygenase P450 BM-3 heme domain using molecular dynamics simulations
R Verma, U Schwaneberg, D Holtmann, D Roccatano
Journal of Chemical Theory and Computation 12 (1), 353-363, 2016
62016
Self-assembly and micellar transition in CTAB solutions triggered by 1-Octanol
V Kumar, KR Mitchell-Koch, SG Marapureddy, R Verma, P Thareja, ...
The Journal of Physical Chemistry B 126 (40), 8102-8111, 2022
32022
Dynamic Preference for NADP/H Cofactor Binding/Release in E. coli YqhD Oxidoreductase
R Verma, J Ellis, K Mitchell-Koch
Molecules 26 (2), 270, 2021
32021
Inside Cover: A Potential Antitumor Drug (Arginine Deiminase) Reengineered for Efficient Operation under Physiological Conditions (ChemBioChem 16/2010)
L Zhu, R Verma, D Roccatano, Y Ni, ZH Sun, U Schwaneberg
ChemBioChem 11 (16), 2194-2194, 2010
12010
Antimicrobial compounds, synthesis methods, and uses thereof
R Verma, KM Donavalli, GH Zaid
US Patent App. 18/327,213, 2024
2024
Low-temperature synthesis of thymoquinone and harmaline compounds
GH Zaid, BA Wolf, RE Ropp, KM Donavalli, R Verma
US Patent US20220160685A1, 2022
2022
Harmine Synthesis
GH Zaid, KM Donavalli, R Verma
US Patent US20220064156A1, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20